William Blair Investment Management LLC Takes Position in Humana Inc. $HUM

William Blair Investment Management LLC acquired a new stake in Humana Inc. (NYSE:HUM) in the 2nd quarter, Holdings Channel.com reports. The institutional investor acquired 34,161 shares of the insurance provider’s stock, valued at approximately $13,569,000.

Other hedge funds also recently added to or reduced their stakes in the company. Revolve Wealth Partners LLC purchased a new position in Humana during the 4th quarter valued at about $202,000. Woodline Partners LP lifted its position in shares of Humana by 460.0% in the 1st quarter. Woodline Partners LP now owns 10,192 shares of the insurance provider’s stock worth $2,697,000 after purchasing an additional 8,372 shares during the period. Sivia Capital Partners LLC boosted its stake in shares of Humana by 53.7% during the second quarter. Sivia Capital Partners LLC now owns 1,293 shares of the insurance provider’s stock valued at $316,000 after purchasing an additional 452 shares in the last quarter. Cresset Asset Management LLC boosted its stake in shares of Humana by 10.3% during the second quarter. Cresset Asset Management LLC now owns 2,369 shares of the insurance provider’s stock valued at $581,000 after purchasing an additional 222 shares in the last quarter. Finally, WINTON GROUP Ltd increased its holdings in Humana by 58.5% during the second quarter. WINTON GROUP Ltd now owns 2,381 shares of the insurance provider’s stock valued at $582,000 after buying an additional 879 shares during the period. 92.38% of the stock is owned by hedge funds and other institutional investors.

Humana Stock Performance

Shares of HUM opened at $379.22 on Friday. Humana Inc. has a 12 month low of $163.11 and a 12 month high of $428.88. The stock has a fifty day moving average price of $383.38 and a 200-day moving average price of $281.59. The company has a current ratio of 1.74, a quick ratio of 1.74 and a debt-to-equity ratio of 0.62. The firm has a market cap of $45.54 billion, a PE ratio of 35.88, a P/E/G ratio of 2.17 and a beta of 0.72.

Humana (NYSE:HUM) last posted its quarterly earnings data on Wednesday, July 29th. The insurance provider reported $7.61 earnings per share for the quarter, topping analysts’ consensus estimates of $7.27 by $0.34. Humana had a return on equity of 11.20% and a net margin of 0.88%.The firm had revenue of $40.89 billion during the quarter, compared to analysts’ expectations of $40.58 billion. During the same quarter last year, the firm earned $6.27 EPS. The business’s quarterly revenue was up 26.2% on a year-over-year basis. Equities research analysts predict that Humana Inc. will post 9.08 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

Several analysts have issued reports on HUM shares. Weiss Ratings raised Humana from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, August 14th. JPMorgan Chase & Co. upped their price objective on Humana from $316.00 to $393.00 and gave the stock a “neutral” rating in a research note on Monday, August 10th. Seaport Research Partners downgraded Humana to a “neutral” rating in a research report on Wednesday, May 20th. Morgan Stanley upgraded Humana from an “underweight” rating to an “equal weight” rating and lifted their target price for the company from $249.00 to $370.00 in a research note on Tuesday, August 4th. Finally, Sanford C. Bernstein reissued an “outperform” rating and set a $425.00 price target on shares of Humana in a research report on Wednesday, June 3rd. Fourteen analysts have rated the stock with a Buy rating, fifteen have issued a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat.com, Humana has a consensus rating of “Hold” and a consensus target price of $395.22.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.